Scandinavian Financial Statements From 2010 to 2025
| CMOTEC-B | SEK 1.66 0.09 5.14% |
Check Scandinavian ChemoTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Scandinavian ChemoTech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Scandinavian financial statements analysis is a perfect complement when working with Scandinavian ChemoTech Valuation or Volatility modules.
Scandinavian |
Scandinavian ChemoTech AB Company Current Valuation Analysis
Scandinavian ChemoTech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Scandinavian ChemoTech Current Valuation | 68.38 M |
Most of Scandinavian ChemoTech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Scandinavian ChemoTech AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Scandinavian ChemoTech AB has a Current Valuation of 68.38 M. This is 99.52% lower than that of the Healthcare sector and 98.53% lower than that of the Biotechnology industry. The current valuation for all Sweden stocks is 99.59% higher than that of the company.
Scandinavian ChemoTech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Scandinavian ChemoTech's current stock value. Our valuation model uses many indicators to compare Scandinavian ChemoTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Scandinavian ChemoTech competition to find correlations between indicators driving Scandinavian ChemoTech's intrinsic value. More Info.Scandinavian ChemoTech AB is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Scandinavian ChemoTech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Scandinavian ChemoTech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Scandinavian ChemoTech Financial Statements
Scandinavian ChemoTech stakeholders use historical fundamental indicators, such as Scandinavian ChemoTech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Scandinavian ChemoTech investors may analyze each financial statement separately, they are all interrelated. For example, changes in Scandinavian ChemoTech's assets and liabilities are reflected in the revenues and expenses on Scandinavian ChemoTech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Scandinavian ChemoTech AB. Please read more on our technical analysis and fundamental analysis pages.
Scandinavian ChemoTech AB provides cancer care and pain management solutions. Scandinavian ChemoTech AB is headquartered in Malmo, Sweden. Scandinavian ChemoTech is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Scandinavian Stock
Scandinavian ChemoTech financial ratios help investors to determine whether Scandinavian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Scandinavian with respect to the benefits of owning Scandinavian ChemoTech security.